DERIVES DE 2-PYRAZINONE DESTINES AU TRAITEMENT D'UNE MALADIE OU D'UN ETAT DANS LEQUEL L'INHIBITION DE L'ELASTASE NEUTROPHILE HUMAINE A UN EFFET BENEFIQUE
The invention provides compounds of formula (I) wherein R1, R3, R4, R5, R14, X and W are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase.